$LEU
CENTRUS ENERGY CORP Stock $leu

$leu Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000106505924000013 Filed on February 09, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$103.6M	$320.2M	$293.8M
YoY Change	-17.91%	8.99%	-1.51%
Cost Of Revenue	$53.80M	$208.1M	$175.9M
YoY Change	-30.85%	18.31%	-4.3%
Gross Profit	$49.80M	$112.1M	$117.9M
YoY Change	2.89%	-4.92%	2.97%
Gross Profit Margin	48.07%	35.01%	40.13%
Selling, General & Admin	$8.200M	$35.60M	$33.90M
YoY Change	-13.68%	5.01%	-5.83%
% of Gross Profit	16.47%	31.76%	28.75%
Research & Development	$3.400M	$14.20M	$14.80M
YoY Change	-29.17%	-4.05%	604.76%
% of Gross Profit	6.83%	12.67%	12.55%
Depreciation & Amortization	$2.300M	$7.100M	$9.600M
YoY Change	-20.69%	-26.04%	11.63%
% of Gross Profit	4.62%	6.33%	8.14%
Operating Expenses	$13.70M	$49.80M	$48.70M
YoY Change	-19.88%	2.26%	27.82%
Operating Profit	$36.10M	$52.40M	$59.70M
YoY Change	15.34%	-12.23%	-12.59%
Interest Expense	$1.900M	$7.400M	$1.500M
YoY Change	137.5%	393.33%
% of Operating Profit	5.26%	14.12%	2.51%
Other Income/Expense, Net	$23.80M	$24.70M	$6.600M
YoY Change	-628.89%	274.24%	-90.24%
Pretax Income	$58.30M	$84.50M	$67.80M
YoY Change	111.23%	24.63%	-50.11%
Income Tax	$2.000M	$100.0K	$15.60M
% Of Pretax Income	3.43%	0.12%	23.01%
Net Earnings	$56.30M	$84.40M	$52.20M
YoY Change	184.34%	61.69%	-70.17%
Net Earnings / Revenue	54.34%	26.36%	17.77%
Basic Earnings Per Share		$5.55	$3.47
Diluted Earnings Per Share	$3.57	$5.44	$3.38
COMMON SHARES
Basic Shares Outstanding		15.21M shares	14.60M shares
Diluted Shares Outstanding		15.50M shares	14.99M shares

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$201.2M	$201.2M	$179.9M
YoY Change	11.84%	11.84%	-7.17%
Cash & Equivalents	$201.2M	$201.2M	$179.9M
Short-Term Investments
Other Short-Term Assets	$10.80M	$10.80M	$24.20M
YoY Change	-55.37%	-55.37%	181.4%
Inventory	$306.4M	$306.4M	$209.2M
Prepaid Expenses
Receivables	$49.40M	$126.8M	$144.8M
Other Receivables	$40.20M	$40.20M	$29.00M
Total Short-Term Assets	$685.4M	$685.4M	$587.1M
YoY Change	16.74%	16.74%	26.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.000M	$9.700M	$13.40M
YoY Change	27.27%	-27.61%	81.08%
Goodwill
YoY Change
Intangibles	$39.40M
YoY Change	-13.79%
Long-Term Investments
YoY Change
Other Assets	$3.500M	$61.70M	$59.30M
YoY Change	-56.79%	4.05%	33.56%
Total Long-Term Assets	$110.8M	$110.8M	$118.4M
YoY Change	-6.42%	-6.42%	11.17%
TOTAL ASSETS
Total Short-Term Assets	$685.4M	$685.4M	$587.1M
Total Long-Term Assets	$110.8M	$110.8M	$118.4M
Total Assets	$796.2M	$796.2M	$705.5M
YoY Change	12.86%	12.86%	23.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$56.20M	$6.100M	$5.900M
YoY Change	-14.2%	3.39%	20.41%
Accrued Expenses		$25.70M	$42.40M
YoY Change		-39.39%	63.71%
Deferred Revenue	$282.6M
YoY Change	3.44%
Short-Term Debt	$0.00	$14.30M	$9.900M
YoY Change		44.44%
Long-Term Debt Due	$6.100M	$6.100M	$6.100M
YoY Change	0.0%	0.0%	0.0%
Total Short-Term Liabilities	$471.1M	$471.1M	$449.2M
YoY Change	4.88%	4.88%	14.21%
LONG-TERM LIABILITIES
Long-Term Debt	$152.7M	$152.7M	$144.4M
YoY Change	5.75%	5.75%	41.85%
Other Long-Term Liabilities	$8.800M	$140.1M	$186.0M
YoY Change	-24.79%	-24.68%	-15.15%
Total Long-Term Liabilities	$8.800M	$292.8M	$330.4M
YoY Change	-24.79%	-11.38%	2.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$471.1M	$471.1M	$449.2M
Total Long-Term Liabilities	$8.800M	$292.8M	$330.4M
Total Liabilities	$763.9M	$763.9M	$779.6M
YoY Change	-2.01%	-2.01%	9.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$149.5M
YoY Change	-36.08%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$32.30M	$32.30M	-$74.10M
YoY Change
Total Liabilities & Shareholders Equity	$796.2M	$796.2M	$705.5M
YoY Change	12.86%	12.86%	23.25%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	$56.30M	$84.40M	$52.20M
YoY Change	184.34%	61.69%	-70.17%
Depreciation, Depletion And Amortization	$2.300M	$7.100M	$9.600M
YoY Change	-20.69%	-26.04%	11.63%
Cash From Operating Activities	$17.90M	$9.100M	$20.60M
YoY Change	-67.86%	-55.83%	-58.8%
INVESTING ACTIVITIES
Capital Expenditures	$500.0K	$1.600M	$700.0K
YoY Change	400.0%	128.57%	-41.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$500.0K	-$1.600M	-$700.0K
YoY Change	400.0%	128.57%	-41.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$23.20M	$3.600M
YoY Change		544.44%	-91.45%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$13.90M	-$4.300M
YoY Change	-100.0%	-423.26%	-56.57%
NET CHANGE
Cash From Operating Activities	17.90M	$9.100M	$20.60M
Cash From Investing Activities	-500.0K	-$1.600M	-$700.0K
Cash From Financing Activities	0.000	$13.90M	-$4.300M
Net Change In Cash	17.40M	$21.40M	$15.60M
YoY Change	-70.71%	37.18%	-59.9%
FREE CASH FLOW
Cash From Operating Activities	$17.90M	$9.100M	$20.60M
Capital Expenditures	$500.0K	$1.600M	$700.0K
Free Cash Flow	$17.40M	$7.500M	$19.90M
YoY Change	-68.71%	-62.31%	-59.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	84500000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15600000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	52200000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	175000000.0	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	175000000.0	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-141900000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	32300000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001065059
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023	dei	Entity File Number EntityFileNumber	1-14287
CY2023	dei	Entity Registrant Name EntityRegistrantName	Centrus Energy Corp.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Bethesda
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20817
CY2023	dei	City Area Code CityAreaCode	(301)
CY2023	dei	Local Phone Number LocalPhoneNumber	564-3200
CY2023	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.10 per share
CY2023	dei	Trading Symbol TradingSymbol	LEU
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	411700000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2023	dei	Auditor Location AuditorLocation	McLean, Virginia
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	179900000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	49400000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38100000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	306400000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	209200000	usd
CY2023Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	117600000	usd
CY2022Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	135700000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10800000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24200000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	685400000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	587100000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7000000.0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5500000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	32400000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	32300000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	39400000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45700000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	28500000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	26800000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3500000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8100000	usd
CY2023Q4	us-gaap	Assets Assets	796200000	usd
CY2022Q4	us-gaap	Assets Assets	705500000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	56200000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	65500000	usd
CY2023Q4	leu	Accounts Payable Under Purchase Agreements Current AccountsPayableUnderPurchaseAgreementsCurrent	41900000	usd
CY2022Q4	leu	Accounts Payable Under Purchase Agreements Current AccountsPayableUnderPurchaseAgreementsCurrent	43600000	usd
CY2023Q4	leu	Inventories Owed To Customers And Suppliers InventoriesOwedToCustomersAndSuppliers	84300000	usd
CY2022Q4	leu	Inventories Owed To Customers And Suppliers InventoriesOwedToCustomersAndSuppliers	60800000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	282600000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	273200000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	6100000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	6100000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	471100000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	449200000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	89600000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	95700000	usd
CY2023Q4	us-gaap	Other Postretirement Defined Benefit Plan Liabilities Noncurrent OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent	81200000	usd
CY2022Q4	us-gaap	Other Postretirement Defined Benefit Plan Liabilities Noncurrent OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent	84500000	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	17300000	usd
CY2022Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	43600000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	32800000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	46200000	usd
CY2023Q4	leu	Long Term Swu Loans LongTermSWULoans	63100000	usd
CY2022Q4	leu	Long Term Swu Loans LongTermSWULoans	48700000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8800000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11700000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	763900000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	779600000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	180500000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	158100000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-149500000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-233900000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-300000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	200000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	32300000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-74100000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	796200000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	705500000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	320200000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	293800000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	298300000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	208100000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	175900000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	183800000	usd
CY2023	us-gaap	Gross Profit GrossProfit	112100000	usd
CY2022	us-gaap	Gross Profit GrossProfit	117900000	usd
CY2021	us-gaap	Gross Profit GrossProfit	114500000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14200000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14800000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2100000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	33900000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	36000000.0	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8100000	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1500000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	84400000	usd
CY2023	leu	Distributed Earnings Allocable To Warrant Modification DistributedEarningsAllocableToWarrantModification	0	usd
CY2022	leu	Distributed Earnings Allocable To Warrant Modification DistributedEarningsAllocableToWarrantModification	1500000	usd
CY2021	leu	Distributed Earnings Allocable To Warrant Modification DistributedEarningsAllocableToWarrantModification	0	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2100000	usd
CY2023	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	0	usd
CY2021	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	37600000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	84400000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	50700000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	135300000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.55
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.47
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.38
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.75
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13493000	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	175000000.0	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9600000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8600000	usd
CY2023	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	20000000.0	usd
CY2022	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	-19500000	usd
CY2021	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	7200000	usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1600000	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-14700000	usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	39500000	usd
CY2023	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	24600000	usd
CY2022	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-7800000	usd
CY2021	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	50500000	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	7400000	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	8000000.0	usd
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense	4800000	usd
CY2023	leu	Equity Related Compensation EquityRelatedCompensation	2300000	usd
CY2022	leu	Equity Related Compensation EquityRelatedCompensation	1900000	usd
CY2021	leu	Equity Related Compensation EquityRelatedCompensation	12100000	usd
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-1600000	usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	usd
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11300000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9000000.0	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-500000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	83800000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	88500000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14200000	usd
CY2023	leu	Increase Decrease In Inventories Owed To Suppliers IncreaseDecreaseInInventoriesOwedToSuppliers	23500000	usd
CY2022	leu	Increase Decrease In Inventories Owed To Suppliers IncreaseDecreaseInInventoriesOwedToSuppliers	52400000	usd
CY2021	leu	Increase Decrease In Inventories Owed To Suppliers IncreaseDecreaseInInventoriesOwedToSuppliers	3500000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-14900000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	15600000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1000000.0	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1700000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	5700000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	16600000	usd
CY2023	leu	Increase Decreasein Deferred Revenue Netof Deferred Costs IncreaseDecreaseinDeferredRevenueNetofDeferredCosts	12100000	usd
CY2022	leu	Increase Decreasein Deferred Revenue Netof Deferred Costs IncreaseDecreaseinDeferredRevenueNetofDeferredCosts	-22500000	usd
CY2021	leu	Increase Decreasein Deferred Revenue Netof Deferred Costs IncreaseDecreaseinDeferredRevenueNetofDeferredCosts	13200000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8500000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2600000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4600000	usd
CY2023	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	-5700000	usd
CY2022	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	-18100000	usd
CY2021	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	-67000000.0	usd
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	800000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	100000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	300000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9100000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20600000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	50000000.0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1600000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	700000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1200000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1600000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-700000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1200000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	23200000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3600000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	42100000	usd
CY2023	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	0	usd
CY2021	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	44400000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	6100000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	6100000	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	6100000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	400000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	900000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3000000.0	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1900000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2400000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-200000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-300000	usd
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13900000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4300000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9900000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	21400000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15600000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	38900000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	212400000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	196800000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157900000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233800000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	212400000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	196800000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-320600000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	42100000	usd
CY2021	leu	Exchange Of Preferred Stock For Common Stock And Common Stock Warrant ExchangeOfPreferredStockForCommonStockAndCommonStockWarrant	0	usd
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	44400000	usd
CY2021	leu	Reclassification Of Stock Based Compensation From Liability To Equity ReclassificationOfStockBasedCompensationFromLiabilityToEquity	7500000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2400000	usd
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-300000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1200000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	52200000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4000000.0	usd
CY2023	leu	Deferred Revenue Change DeferredRevenueChange	-6000000.0	usd
CY2023Q4	leu	Contract With Customer Advances Liability Current ContractWithCustomerAdvancesLiabilityCurrent	30200000	usd
CY2022	leu	Reclassification Of Stock Based Compensation From Liability To Equity ReclassificationOfStockBasedCompensationFromLiabilityToEquity	10600000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1900000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	0	usd
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-300000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3200000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-74100000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	84400000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	23200000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3000000.0	usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-500000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2300000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts presented and disclosed in the Consolidated Financial Statements. Significant estimates and judgments include, but are not limited to, revenue and related costs, asset valuations, pension and postretirement health and life benefit costs and obligations, the tax bases of assets and liabilities, the future recoverability of deferred tax assets, and determination of the valuation allowance for deferred tax assets. Actual results may differ from such estimates, and estimates may change if the underlying conditions or assumptions change.</span></div>
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Credit risk could result from the possibility of a customer failing to perform or pay according to the terms of a contract. Extension of credit is based on an evaluation of each customer’s financial condition. Centrus regularly monitors credit risk exposure and takes steps intended to mitigate the likelihood of such exposure resulting in a loss.</span></div>
CY2023	us-gaap	Concentration Risk Supplier ConcentrationRiskSupplier	Concentrations of Supply Risk and Other Considerations with the War in Ukraine The current war in Ukraine has led to the U.S., Russia and other countries imposing sanctions and other measures that restrict international trade. The situation is rapidly changing, and it is not possible to predict future actions that could be taken. The Company has multiple sources of supply; however, the supply contract with TENEX remains the Company’s largest source and accounts for well over one-half of or its anticipated supply in 2024-2027 for deliveries to U.S. customers. At present, sanctions have not impacted the ability of the Company or TENEX to perform under the TENEX Supply Contract. Recently, sanctions have been imposed by the U.S. on exports of fossil fuels. Russia has imposed sanctions on the export of commodities but does not include the export of LEU. Canada has imposed sanctions on ocean transportation of Russian LEU, but has given a permit to the Company’s carrier that extends to early July 2024. Additional sanctions or other measures by the U.S. or foreign governments (including the Russian government) could be imposed or the existing Canadian permit might not be extended. Any sanctions or measures directed at trade in LEU from Russia or the parties involved in such trade or otherwise, including denial or non-renewal of licenses or permits, could interfere with, or prevent, implementation of the TENEX Supply Contract. While the initial sanctions announced do not affect the ability of the Company or TENEX to implement the TENEX Supply Contract, the situation at this time is unpredictable and there are proposals in Congress (including one that has passed the House of Representatives) to impose a ban on imports of Russian LEU. If a ban were enacted or measures were taken to limit the supply of Russian LEU or to prohibit or limit dealings with Russian entities, including, but not limited to, TENEX or Rosatom, the Company would seek a license, waiver or other approval from the government imposing such measures to ensure that the Company could continue to fulfill its purchase and sales obligations. There is no assurance that such a license, waiver, or approval would be granted. If a license, waiver or approval were not granted, the Company would need to look to alternative sources of LEU to replace the LEU that it could not procure from TENEX. The Company has contracts for alternative sources that could be used to mitigate a portion of the near term impacts. However, the Company’s alternative sources are not sufficient to replace all of the Russian LEU the Company is currently permitted to import under the RSA, and to the extent additional supply cannot be obtained, or obtained at a higher costs, it will have a material adverse impact on its business, results of operations, and competitive position.Given the foregoing, there is no assurance that future developments would not have a material adverse effect on the Company’s procurement, payment, delivery or sale of LEU under the TENEX Supply Contract and well as on our business, results of operations, and competitive position.
CY2023	leu	Provision For Loss On Contract Change ProvisionForLossOnContractChange	-20000000.0	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	252400000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	258400000	usd
CY2023	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	Related Party As previously disclosed in the Company’s Current Report on Form 8-K filed on December 31, 2020, on that same date the Company entered into an At Market Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. and Lake Street Capital Markets, LLC, relating to an ATM offering of shares of the Company’s Class A Common Stock. Mr. Williams, Chairman of the Centrus Board of Directors, also served on the board of B. Riley Financial, Inc. Mr. Williams recused himself and took no part in the selection of B. Riley or the negotiation of the terms of the Sales Agreement. The Company filed a shelf registration statement on Form S-3 (Registration Statement No. 333-272984) with the SEC on June 28, 2023, which became effective on July 10, 2023. Pursuant to this shelf registration statement, the Company may offer and sell up to $200 million in securities, in aggregate. The Company may continue to work with B. Riley Securities, Inc. for any offerings under this registration statement. Mr. Williams is an employee of Targus International LLC whose ultimate parent has been B. Riley Financial, Inc since 2022. Please refer to Note 16, Stockholders’ Equity, for further details.Foreign CurrencyThe Company records foreign currency transaction gains and losses, realized and unrealized, and foreign exchange gains and losses due to re-measurement of monetary assets and liabilities that are not denominated in U.S. dollars in other income, net in the Consolidated Statements of Operations.
CY2023Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	40200000	usd
CY2022Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	29000000.0	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	9200000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	9100000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	49400000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38100000	usd
CY2023Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	0	usd
CY2022Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	20000000.0	usd
CY2022Q4	leu	Contract With Customer Advances Liability Current ContractWithCustomerAdvancesLiabilityCurrent	14800000	usd
CY2023	leu	Advances From Customers Change AdvancesFromCustomersChange	15400000	usd
CY2023Q4	leu	Contract With Customer Advances Liability Noncurrent ContractWithCustomerAdvancesLiabilityNoncurrent	32800000	usd
CY2022Q4	leu	Contract With Customer Advances Liability Noncurrent ContractWithCustomerAdvancesLiabilityNoncurrent	46200000	usd
CY2023	leu	Advances From Customers Noncurrent Change AdvancesFromCustomersNoncurrentChange	-13400000	usd
CY2023	leu	Deferred Revenue Additions In Period DeferredRevenueAdditionsInPeriod	33400000	usd
CY2022	leu	Deferred Revenue Additions In Period DeferredRevenueAdditionsInPeriod	33700000	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	23600000	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	62400000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1000000000.0	usd
CY2023Q4	leu	Deferred Revenue And Advances From Customers Current And Noncurrent DeferredRevenueAndAdvancesFromCustomersCurrentAndNoncurrent	315000000	usd
CY2022Q4	leu	Deferred Revenue And Advances From Customers Current And Noncurrent DeferredRevenueAndAdvancesFromCustomersCurrentAndNoncurrent	319000000	usd
CY2023	us-gaap	Nonmonetary Transaction Gross Operating Revenue Recognized NonmonetaryTransactionGrossOperatingRevenueRecognized	14800000	usd
CY2022	us-gaap	Nonmonetary Transaction Gross Operating Revenue Recognized NonmonetaryTransactionGrossOperatingRevenueRecognized	14500000	usd
CY2021	us-gaap	Nonmonetary Transaction Gross Operating Revenue Recognized NonmonetaryTransactionGrossOperatingRevenueRecognized	0	usd
CY2023Q4	leu	Contract With Customer Advances Liability ContractWithCustomerAdvancesLiability	63000000.0	usd
CY2022Q4	leu	Contract With Customer Advances Liability ContractWithCustomerAdvancesLiability	61000000.0	usd
CY2023Q4	leu	Governmentcostshareportion Governmentcostshareportion	173000000.0	usd
CY2023	leu	Provision For Loss On Contracts Utilized ProvisionForLossOnContractsUtilized	0	usd
CY2022	leu	Provision For Loss On Contracts Utilized ProvisionForLossOnContractsUtilized	500000	usd
CY2021	leu	Provision For Loss On Contracts Utilized ProvisionForLossOnContractsUtilized	-7200000	usd
	leu	Provision For Loss On Contracts Utilized ProvisionForLossOnContractsUtilized	19600000	usd
CY2022	leu	Accrued Loss AccruedLoss	21300000	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	43500000	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	43500000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	201200000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	179900000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	200000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	200000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	32400000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	32300000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233800000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	212400000	usd
CY2023Q4	us-gaap	Cash Held In Foreign Currency CashHeldInForeignCurrency	6800000	usd
CY2022Q4	us-gaap	Cash Held In Foreign Currency CashHeldInForeignCurrency	0	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	100000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	100000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	100000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	8900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9100000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	200000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	32400000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	200000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	32300000	usd
CY2023Q4	leu	Separative Work Units Inventory SeparativeWorkUnitsInventory	21900000	usd
CY2023Q4	leu	Separative Work Units Owed To Customers And Suppliers SeparativeWorkUnitsOwedToCustomersAndSuppliers	0	usd
CY2023Q4	leu	Separative Work Units Net Of Liability SeparativeWorkUnitsNetOfLiability	21900000	usd
CY2022Q4	leu	Separative Work Units Inventory SeparativeWorkUnitsInventory	24100000	usd
CY2022Q4	leu	Separative Work Units Owed To Customers And Suppliers SeparativeWorkUnitsOwedToCustomersAndSuppliers	0	usd
CY2022Q4	leu	Separative Work Units Net Of Liability SeparativeWorkUnitsNetOfLiability	24100000	usd
CY2023Q4	leu	Uranium Inventory UraniumInventory	284500000	usd
CY2023Q4	leu	Uranium Owed To Customers And Suppliers UraniumOwedToCustomersAndSuppliers	84300000	usd
CY2023Q4	leu	Uranium Inventory Net Of Liability UraniumInventoryNetOfLiability	200200000	usd
CY2022Q4	leu	Uranium Inventory UraniumInventory	185100000	usd
CY2022Q4	leu	Uranium Owed To Customers And Suppliers UraniumOwedToCustomersAndSuppliers	60800000	usd
CY2022Q4	leu	Uranium Inventory Net Of Liability UraniumInventoryNetOfLiability	124300000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	306400000	usd
CY2023Q4	leu	Inventories Owed To Customers And Suppliers InventoriesOwedToCustomersAndSuppliers	84300000	usd
CY2023Q4	leu	Inventory Net Of Liability InventoryNetOfLiability	222100000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	209200000	usd
CY2022Q4	leu	Inventories Owed To Customers And Suppliers InventoriesOwedToCustomersAndSuppliers	60800000	usd
CY2022Q4	leu	Inventory Net Of Liability InventoryNetOfLiability	148400000	usd
CY2023	leu	Uf6 Units Borrowed In Period UF6UnitsBorrowedInPeriod	22500000	usd
CY2023	leu	Separative Work Units Repaid In Period Value SeparativeWorkUnitsRepaidInPeriodValue	-11100000	usd
CY2022Q1	leu	Separative Work Units Borrowed In Period Value SeparativeWorkUnitsBorrowedInPeriodValue	9400000	usd
CY2022Q2	leu	Separative Work Units Borrowed In Period Value SeparativeWorkUnitsBorrowedInPeriodValue	8500000	usd
CY2022Q4	leu	Separative Work Units Borrowed In Period Value SeparativeWorkUnitsBorrowedInPeriodValue	10400000	usd
	leu	Separative Work Units Borrowed In Period Value SeparativeWorkUnitsBorrowedInPeriodValue	20700000	usd
CY2021Q4	leu	Separativeworkunitsowedtoothersnoncurrent Separativeworkunitsowedtoothersnoncurrent	3100000	usd
CY2023Q4	leu	Separativeworkunitsowedtoothersnoncurrent Separativeworkunitsowedtoothersnoncurrent	11100000	usd
CY2023	leu	Separative Work Units Valuation Change In Period SeparativeWorkUnitsValuationChangeInPeriod	7400000	usd
CY2022	leu	Separative Work Units Valuation Change In Period SeparativeWorkUnitsValuationChangeInPeriod	7900000	usd
CY2021	leu	Separative Work Units Valuation Change In Period SeparativeWorkUnitsValuationChangeInPeriod	4800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6000000.0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9100000	usd
CY2023	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	2200000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11300000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3600000	usd
CY2023	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	700000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4300000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5500000	usd
CY2023	leu	Property Plant And Equipment Net Capital Expenditures PropertyPlantAndEquipmentNetCapitalExpenditures	1500000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7000000.0	usd
CY2023	us-gaap	Depreciation Depreciation	700000	usd
CY2022	us-gaap	Depreciation Depreciation	600000	usd
CY2021	us-gaap	Depreciation Depreciation	600000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	123500000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	84100000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	39400000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	123500000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	77800000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45700000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4600000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	39400000	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	6100000	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	5900000	usd
CY2023Q4	leu	Compensation And Benefits Payable CompensationAndBenefitsPayable	21100000	usd
CY2022Q4	leu	Compensation And Benefits Payable CompensationAndBenefitsPayable	15700000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent	10100000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent	7300000	usd
CY2023Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	0	usd
CY2022Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	20000000.0	usd
CY2023Q4	leu	Short Term Inventory Loan ShortTermInventoryLoan	14300000	usd
CY2022Q4	leu	Short Term Inventory Loan ShortTermInventoryLoan	9900000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1400000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3300000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3200000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3400000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	56200000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	65500000	usd
CY2023Q4	leu	Subordinationtocreditfacilityfacilitytotal Subordinationtocreditfacilityfacilitytotal	50000000	usd
CY2023Q4	leu	Subordinationtocreditfacilityfacilitymaximumnetborrowing Subordinationtocreditfacilityfacilitymaximumnetborrowing	40000000	usd
CY2023Q4	leu	Subordinationtocreditfacilityfacilitytotal Subordinationtocreditfacilityfacilitytotal	50000000	usd
CY2023Q4	leu	Subordinationtocreditfacilityfacilitymaximumnetborrowing Subordinationtocreditfacilityfacilitymaximumnetborrowing	40000000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.113
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.101
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	100000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	500000	usd
CY2023	leu	Operatingleaseexpenseadjustment Operatingleaseexpenseadjustment	1500000	usd
CY2022	leu	Operatingleaseexpenseadjustment Operatingleaseexpenseadjustment	1600000	usd
CY2021	leu	Operatingleaseexpenseadjustment Operatingleaseexpenseadjustment	2000000.0	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1700000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1600000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	2400000	usd
CY2022	leu	Operating Lease Liability Decrease OperatingLeaseLiabilityDecrease	-1000000.0	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	6600000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2700000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7900000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1400000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3300000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2600000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6100000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4000000.0	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9400000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1900000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1900000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1000000.0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	800000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5600000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1600000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4000000.0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	201200000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	179900000	usd
CY2023Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	3300000	usd
CY2022Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	2400000	usd
CY2023Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	3300000	usd
CY2022Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	2400000	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	43500000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear	0.070
CY2022Q4	us-gaap	Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear	0.070
CY2023Q4	us-gaap	Defined Benefit Plan Ultimate Health Care Cost Trend Rate1 DefinedBenefitPlanUltimateHealthCareCostTrendRate1	0.05
CY2022Q4	us-gaap	Defined Benefit Plan Ultimate Health Care Cost Trend Rate1 DefinedBenefitPlanUltimateHealthCareCostTrendRate1	0.05
CY2023	us-gaap	Defined Benefit Plan Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate	2032
CY2022	us-gaap	Defined Benefit Plan Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate	2031
CY2023Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1
CY2022Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1
CY2023Q4	leu	Defined Benefit Plan Investments Measured At Nav DefinedBenefitPlanInvestmentsMeasuredAtNAV	35200000	usd
CY2022Q4	leu	Defined Benefit Plan Investments Measured At Nav DefinedBenefitPlanInvestmentsMeasuredAtNAV	105800000	usd
CY2023Q4	leu	Accruedinterestreceivable Accruedinterestreceivable	500000	usd
CY2022Q4	leu	Accruedinterestreceivable Accruedinterestreceivable	600000	usd
CY2023Q4	leu	Unsettledtransactionsreceivable Unsettledtransactionsreceivable	0	usd
CY2022Q4	leu	Unsettledtransactionsreceivable Unsettledtransactionsreceivable	-300000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	291000000.0	usd
CY2022Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	486800000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2300000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2100000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	3600000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	3600000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	500000	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1900000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	561704	shares
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1400000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P48M
CY2023	leu	Stock Appreciation Rights Expense StockAppreciationRightsExpense	1000000.0	usd
CY2022	leu	Stock Appreciation Rights Expense StockAppreciationRightsExpense	900000	usd
CY2021	leu	Stock Appreciation Rights Expense StockAppreciationRightsExpense	11600000	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	0	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	100000	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	100000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2300000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1900000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12200000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-300000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-200000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-1500000	usd
CY2023Q4	leu	Board Restricted Stock Units Potentially Converted To Common Stock Shares BoardRestrictedStockUnitsPotentiallyConvertedToCommonStockShares	160000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	411000	shares
CY2020Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	4.18
CY2020	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y3M18D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7800000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	217000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.17
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	194000	shares
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	4.18
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y4M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8900000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	98000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.00
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96000	shares
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	4.37
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y2M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2700000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96000	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	4.37
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P0Y3M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4800000	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	96000	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	4.37
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y3M18D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4800000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1600000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1000000.0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	400000	usd
CY2023	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-1500000	usd
CY2022	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	14600000	usd
CY2021	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-39500000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15600000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-39100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	27100000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	33500000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	31300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	21300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	178000000.0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	190200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3500000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	172000000.0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	188600000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	4900000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	5500000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	7600000	usd
CY2023Q4	leu	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	800000	usd
CY2022Q4	leu	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	2100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	400000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	419000000.0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	452100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	382400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	414100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	36600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	38000000.0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	7100000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	9000000.0	usd
CY2023Q4	leu	Deferred Tax Liability Lease Asset DeferredTaxLiabilityLeaseAsset	600000	usd
CY2022Q4	leu	Deferred Tax Liability Lease Asset DeferredTaxLiabilityLeaseAsset	1800000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Other Capitalized Costs DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts	400000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Other Capitalized Costs DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts	400000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	8100000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	11200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	28500000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	26800000	usd
CY2023Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7700000	usd
CY2023Q4	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	11700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	382400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	414100000	usd
CY2018Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	568000000.0	usd
CY2023Q4	leu	Operating Loss Carryforwards No Expiration OperatingLossCarryforwardsNoExpiration	131400000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	84400000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	52200000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	175000000.0	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2100000	usd
CY2023	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.38
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.01
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.53
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.01
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.01
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.01
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.23
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.29
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	31700000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	600000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	71300000	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	2900000	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1900000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	1000000.0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	900000	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1900000	usd
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1000000.0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1000000.0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	900000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	2900000	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1900000	usd
CY2023	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	200000	usd
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	100000	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	300000	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	100000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	21.62
CY2021Q4	leu	Preferred Stock Liquidation Amount Per Share PreferredStockLiquidationAmountPerShare	1291.04
CY2021Q4	leu	Stock Repurchase Price Per Share StockRepurchasePricePerShare	1149.99
CY2021Q4	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	43300000	usd
CY2021	leu	Aggregate Value Preferred Stock Transactions AggregateValuePreferredStockTransactions	50800000	usd
CY2021	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	37600000	usd
CY2021	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	37600000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	84400000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	50700000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	135300000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15212000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14601000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13493000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	289000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	387000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	386000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15501000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14988000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13879000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.55
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.47
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.03
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.44
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.38
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.75
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15675634	shares
CY2021	leu	Preferred Stock Retired Liquidation Preference PreferredStockRetiredLiquidationPreference	5000198	usd
CY2021Q4	leu	Conversion Of Stock Share Price ConversionOfStockSharePrice	21.62
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	21.62
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	21.62
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	0	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1900000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	561704	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	104574	shares
CY2020Q4	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	60000000	usd
CY2021Q3	leu	Preferred Stock Liquidation Amount Per Share PreferredStockLiquidationAmountPerShare	1347.29
CY2021Q4	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	42200000	usd
CY2021Q4	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	1100000	usd
CY2021Q4	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	43300000	usd
CY2023Q4	leu	Common Stock Ownership Enabling Preferred Stock Purchase Rights CommonStockOwnershipEnablingPreferredStockPurchaseRights	0.0499
CY2023Q4	leu	Common Stock Ownership Enabling Preferred Stock Purchase Rights Incremental CommonStockOwnershipEnablingPreferredStockPurchaseRightsIncremental	0.005
CY2023Q4	us-gaap	Loss Contingency Range Of Possible Loss Portion Not Accrued LossContingencyRangeOfPossibleLossPortionNotAccrued	9600000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	320200000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	293800000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	298300000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001065059-24-000013-index-headers.html	Edgar Link	pending
0001065059-24-000013-index.html	Edgar Link	pending
0001065059-24-000013.txt	Edgar Link	pending
0001065059-24-000013-xbrl.zip	Edgar Link	pending
exhibit_1089x20231231xha.htm	Edgar Link	pending
exhibit_1089x20231231xha001.jpg	Edgar Link	pending
exhibit_1089x20231231xha002.jpg	Edgar Link	pending
exhibit_1089x20231231xha003.jpg	Edgar Link	pending
exhibit_1091x20231231x20.htm	Edgar Link	pending
exhibit_1091x20231231x20001.jpg	Edgar Link	pending
exhibit_1091x20231231x20002.jpg	Edgar Link	pending
exhibit_1091x20231231x20003.jpg	Edgar Link	pending
exhibit_1091x20231231x20004.jpg	Edgar Link	pending
exhibit_1091x20231231x20005.jpg	Edgar Link	pending
exhibit_1091x20231231x20006.jpg	Edgar Link	pending
exhibit_1091x20231231x20007.jpg	Edgar Link	pending
exhibit_1091x20231231x20008.jpg	Edgar Link	pending
exhibit_1091x20231231x20009.jpg	Edgar Link	pending
exhibit_1091x20231231x20010.jpg	Edgar Link	pending
exhibit_1091x20231231x20011.jpg	Edgar Link	pending
exhibit_1091x20231231x20012.jpg	Edgar Link	pending
exhibit_1091x20231231x20013.jpg	Edgar Link	pending
exhibit_1091x20231231x20014.jpg	Edgar Link	pending
exhibit_1091x20231231x20015.jpg	Edgar Link	pending
exhibit_1091x20231231x20016.jpg	Edgar Link	pending
exhibit_1091x20231231x20017.jpg	Edgar Link	pending
exhibit_1092x20231231xve.htm	Edgar Link	pending
exhibit_1092x20231231xve001.jpg	Edgar Link	pending
exhibit_1092x20231231xve002.jpg	Edgar Link	pending
exhibit_1092x20231231xve003.jpg	Edgar Link	pending
exhibit_1092x20231231xve004.jpg	Edgar Link	pending
exhibit_1092x20231231xve005.jpg	Edgar Link	pending
exhibit_1092x20231231xve006.jpg	Edgar Link	pending
exhibit_19x20231231xinsi.htm	Edgar Link	pending
exhibit_19x20231231xinsi001.jpg	Edgar Link	pending
exhibit_19x20231231xinsi002.jpg	Edgar Link	pending
exhibit_19x20231231xinsi003.jpg	Edgar Link	pending
exhibit_19x20231231xinsi004.jpg	Edgar Link	pending
exhibit_19x20231231xinsi005.jpg	Edgar Link	pending
exhibit_19x20231231xinsi006.jpg	Edgar Link	pending
exhibit_19x20231231xinsi007.jpg	Edgar Link	pending
exhibit_19x20231231xinsi008.jpg	Edgar Link	pending
exhibit_19x20231231xinsi009.jpg	Edgar Link	pending
exhibit_19x20231231xinsi010.jpg	Edgar Link	pending
exhibit_19x20231231xinsi011.jpg	Edgar Link	pending
exhibit_19x20231231xinsi012.jpg	Edgar Link	pending
exhibit_19x20231231xinsi013.jpg	Edgar Link	pending
exhibit_19x20231231xinsi014.jpg	Edgar Link	pending
exhibit_19x20231231xinsi015.jpg	Edgar Link	pending
exhibit_21x20231231xlistof.htm	Edgar Link	pending
exhibit_231x20231231x202.htm	Edgar Link	pending
exhibit_231x20231231x202001.jpg	Edgar Link	pending
exhibit_232x20231231xpwc.htm	Edgar Link	pending
exhibit_232x20231231xpwc001.jpg	Edgar Link	pending
exhibit_311x20231231.htm	Edgar Link	pending
exhibit_312x20231231.htm	Edgar Link	pending
exhibit_321x20231231.htm	Edgar Link	pending
exhibit_417x20231231xdescr.htm	Edgar Link	pending
exhibit_97x20231231xclawba.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
leu-20231231.htm	Edgar Link	pending
leu-20231231.xsd	Edgar Link	pending
leu-20231231_g1.jpg	Edgar Link	pending
leu-20231231_g2.jpg	Edgar Link	pending
leu-20231231_g3.jpg	Edgar Link	pending
leu-20231231_g4.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
leu-20231231_cal.xml	Edgar Link	unprocessable
leu-20231231_def.xml	Edgar Link	unprocessable
leu-20231231_lab.xml	Edgar Link	unprocessable
leu-20231231_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
leu-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LEU
CENTRUS ENERGY CORP Stock $leu

2023 Q4 Form 10-K Financial Statement

#000106505924000013 Filed on February 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LEU CENTRUS ENERGY CORP Stock $leu

2023 Q4 Form 10-K Financial Statement

#000106505924000013 Filed on February 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LEU
CENTRUS ENERGY CORP Stock $leu